Harbor Capital Advisors Inc. Has $6.69 Million Stock Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Harbor Capital Advisors Inc. boosted its position in OrthoPediatrics Corp. (NASDAQ:KIDS) by 268.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 246,860 shares of the company’s stock after buying an additional 179,803 shares during the quarter. Harbor Capital Advisors Inc.’s holdings in OrthoPediatrics were worth $6,692,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the company. International Assets Investment Management LLC boosted its holdings in OrthoPediatrics by 2,610.8% during the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after acquiring an additional 966 shares during the period. Quest Partners LLC bought a new stake in OrthoPediatrics during the 2nd quarter valued at approximately $34,000. EntryPoint Capital LLC boosted its stake in OrthoPediatrics by 56.9% during the 1st quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock valued at $81,000 after purchasing an additional 1,009 shares during the period. SG Americas Securities LLC acquired a new stake in OrthoPediatrics in the 2nd quarter valued at approximately $110,000. Finally, State Board of Administration of Florida Retirement System bought a new position in OrthoPediatrics in the 1st quarter worth approximately $178,000. Institutional investors own 69.05% of the company’s stock.

Insider Buying and Selling

In other OrthoPediatrics news, General Counsel Daniel J. Gerritzen sold 10,000 shares of OrthoPediatrics stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $29.30, for a total transaction of $293,000.00. Following the sale, the general counsel now directly owns 77,304 shares of the company’s stock, valued at approximately $2,265,007.20. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 31.80% of the company’s stock.

OrthoPediatrics Price Performance

Shares of NASDAQ:KIDS opened at $27.36 on Friday. The business’s 50 day moving average is $28.07 and its 200-day moving average is $29.86. The company has a current ratio of 4.90, a quick ratio of 1.96 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $662.39 million, a PE ratio of -25.10 and a beta of 1.16. OrthoPediatrics Corp. has a 1-year low of $24.02 and a 1-year high of $36.23.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings results on Monday, August 5th. The company reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.31) by $0.08. The firm had revenue of $52.80 million for the quarter, compared to analyst estimates of $52.40 million. OrthoPediatrics had a negative net margin of 14.35% and a negative return on equity of 5.44%. Sell-side analysts predict that OrthoPediatrics Corp. will post -0.92 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on KIDS. JMP Securities reissued a “market outperform” rating and issued a $50.00 price objective on shares of OrthoPediatrics in a research report on Friday, September 13th. Needham & Company LLC reissued a “buy” rating and issued a $42.00 price target on shares of OrthoPediatrics in a report on Friday, September 13th. Finally, Truist Financial dropped their price objective on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a report on Monday, October 14th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.